Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akili, B-Secur, Evotec, Exero, Fire1, Head Diagnostics, Innovheart, NH Theraguix, Virtual Therapeutics.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Hanall, Turn, Vaxil.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Canary Medical, Cancer Check Labs, Mannkind, Pulmatrix, Surmodics.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 92Bio, Amarin, Angelini, Bio-Sourcing, Biontech, BMS, Cartography, Clene, Daiichi Sankyo, Evotec, Flerie, Gilead, Helsinn, Icosagen, Illumina, Index, Inhibrx, Integrated Biosciences, Intract, Leveragen, Medilink, Menten, Orbit, Revolka, Secarna, Vianex, YS Biopharma.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Hitachi, Hyperfine, Opgen, OCT Clinical, Palleos, Radiosurgery Global, Realheart, Roche, Xlife.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Alvotech, Cipla, Deimos, Dr. Reddy’s, Exelisis, G1, Innunis, Genor, Otsuka, Pepper Bio, Qurient, Sun Pharmaceuticals, Taro, Toray.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amphista, Cytokinetics, Idorsia, Immunis, Orna, Owkin, Providence, Renegade, Sinaptica, Sun, Tango, Taro, Toray.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alma, Autonomix, Exicure Heartbeat Health, Karoo Health, Stereotaxis.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Achilles, Arcturus, Deimos, Dimerx, Etherna, G1, Genmab, Genor, Legend, Maxcyte, Pepper, Profoundbio, Temple Street.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Better Therapeutics, Click Therapeutics, Lensabl, Oxford Biodynamics, Visibly.